# A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.

> **NCT05582187** · PHASE1 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 28 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Fosmanogepix

## Key facts

- **NCT ID:** NCT05582187
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-31
- **Primary completion:** 2025-10-16
- **Final completion:** 2025-10-16
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582187, "A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05582187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*